Clinical trials
Phase 2/3 Atherosclerosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute on Aging (NIA) | 3 |
| Anesiva, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| CSL Behring | 1 |
| Chugai Pharma USA | 1 |
| Daiichi Sankyo | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Ohio State University | 1 |
| Oregon State University | 1 |
| Parke-Davis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 13 |
| Cardiovascular Diseases | 4 |
| Coronary Artery Disease | 2 |
| Diabetes Mellitus | 2 |
| Graft Occlusion, Vascular | 2 |
| Inflammation | 2 |
| Insulin Resistance | 2 |
| Myocardial Infarction | 2 |
| Arterial Occlusive Diseases | 1 |
| Coronary Restenosis | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.